ZA994406B - Meta-azacyclic amino benzoic acid and derivatives thereof. - Google Patents

Meta-azacyclic amino benzoic acid and derivatives thereof.

Info

Publication number
ZA994406B
ZA994406B ZA9904406A ZA994406A ZA994406B ZA 994406 B ZA994406 B ZA 994406B ZA 9904406 A ZA9904406 A ZA 9904406A ZA 994406 A ZA994406 A ZA 994406A ZA 994406 B ZA994406 B ZA 994406B
Authority
ZA
South Africa
Prior art keywords
meta
derivatives
benzoic acid
amino benzoic
azacyclic amino
Prior art date
Application number
ZA9904406A
Other languages
English (en)
Inventor
Thomas E Rogers
Peter G Ruminski
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of ZA994406B publication Critical patent/ZA994406B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/12Nitrogen atoms not forming part of a nitro radical
    • C07D239/14Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to said nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
ZA9904406A 1998-03-04 1999-02-11 Meta-azacyclic amino benzoic acid and derivatives thereof. ZA994406B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3427098A 1998-03-04 1998-03-04

Publications (1)

Publication Number Publication Date
ZA994406B true ZA994406B (en) 2000-02-11

Family

ID=21875345

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9904406A ZA994406B (en) 1998-03-04 1999-02-11 Meta-azacyclic amino benzoic acid and derivatives thereof.

Country Status (29)

Country Link
EP (1) EP1060164A1 (id)
JP (1) JP2002505323A (id)
KR (1) KR20010041584A (id)
CN (1) CN1214011C (id)
AP (1) AP1244A (id)
AR (1) AR018139A1 (id)
AU (1) AU753230B2 (id)
BG (1) BG104740A (id)
BR (1) BR9908470A (id)
CA (1) CA2322207A1 (id)
EA (1) EA200000804A1 (id)
EE (1) EE200000506A (id)
GE (1) GEP20033118B (id)
HR (1) HRP20000574A2 (id)
HU (1) HUP0100865A3 (id)
ID (1) ID25591A (id)
IL (1) IL137653A0 (id)
IS (1) IS5582A (id)
MY (1) MY123908A (id)
NO (1) NO315703B1 (id)
NZ (1) NZ506598A (id)
OA (1) OA11530A (id)
PL (1) PL342726A1 (id)
SK (1) SK13002000A3 (id)
TR (1) TR200002542T2 (id)
UA (1) UA71906C2 (id)
WO (1) WO1999044994A1 (id)
YU (1) YU52000A (id)
ZA (1) ZA994406B (id)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9805655D0 (en) 1998-03-16 1998-05-13 Celltech Therapeutics Ltd Chemical compounds
GB9814414D0 (en) 1998-07-03 1998-09-02 Celltech Therapeutics Ltd Chemical compounds
GB9821061D0 (en) 1998-09-28 1998-11-18 Celltech Therapeutics Ltd Chemical compounds
GB9826174D0 (en) 1998-11-30 1999-01-20 Celltech Therapeutics Ltd Chemical compounds
US6518283B1 (en) 1999-05-28 2003-02-11 Celltech R&D Limited Squaric acid derivatives
US6455539B2 (en) 1999-12-23 2002-09-24 Celltech R&D Limited Squaric acid derivates
WO2001079173A2 (en) 2000-04-17 2001-10-25 Celltech R & D Limited Enamine derivatives as cell adhesion molecules
US6403608B1 (en) 2000-05-30 2002-06-11 Celltech R&D, Ltd. 3-Substituted isoquinolin-1-yl derivatives
US6545013B2 (en) 2000-05-30 2003-04-08 Celltech R&D Limited 2,7-naphthyridine derivatives
US6921767B2 (en) * 2000-06-15 2005-07-26 Pharmacia Corporation Cycloalkyl alkanoic acids as integrin receptor antagonists derivatives
CA2417059A1 (en) 2000-08-02 2002-02-07 Celltech R&D Limited 3-substituted isoquinolin-1-yl derivatives
CA2510050A1 (en) * 2002-12-20 2004-07-22 Pharmacia Corporation The r-isomer of beta amino acid compounds as integrin receptor antagonists derivatives
UA87854C2 (en) 2004-06-07 2009-08-25 Мерк Энд Ко., Инк. N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
KR20080031266A (ko) * 2005-06-10 2008-04-08 바이파 사이언스 인코포레이티드 Parp 조절제 및 암의 치료
EP2131861A2 (en) 2007-03-01 2009-12-16 Mallinckrodt Inc. Integrated photoactive small molecules and uses thereof
JP4792124B1 (ja) * 2010-11-15 2011-10-12 エフイートレード株式会社 車両用保護フィルムの型取り方法、及び、車両用保護フィルムの製造方法
US8716226B2 (en) 2012-07-18 2014-05-06 Saint Louis University 3,5 phenyl-substituted beta amino acid derivatives as integrin antagonists
CN104640857B (zh) 2012-07-18 2017-07-04 圣路易斯大学 作为整合素拮抗剂的β氨基酸衍生物
KR20160147007A (ko) 2014-05-30 2016-12-21 화이자 인코포레이티드 선택적인 안드로겐 수용체 조절제로서의 카보니트릴 유도체
US9856201B2 (en) * 2014-06-04 2018-01-02 Monsanto Technology Llc 3,6-dichlorosalicylic acid compounds and related synthetic processes
SG11201805387RA (en) 2015-12-30 2018-07-30 Univ Saint Louis Meta-azacyclic amino benzoic acid derivatives as pan integrin antagonists
MX2022014200A (es) 2020-05-14 2022-12-07 Ube Corp Derivado de 1,4,5,6-tetrahidropirimidin-2-amina.
WO2023275715A1 (en) 2021-06-30 2023-01-05 Pfizer Inc. Metabolites of selective androgen receptor modulators
JPWO2023085396A1 (id) 2021-11-12 2023-05-19

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE203234T1 (de) * 1995-08-30 2001-08-15 Searle & Co Meta-guanidine, harnstoff, thioharnstoff oder azacyklische aminobenzoesäure-derivate als integrin antagonisten

Also Published As

Publication number Publication date
NO20004316L (no) 2000-11-06
WO1999044994A1 (en) 1999-09-10
IS5582A (is) 2000-08-04
MY123908A (en) 2006-06-30
BR9908470A (pt) 2000-12-05
YU52000A (sh) 2003-02-28
EE200000506A (et) 2002-04-15
CA2322207A1 (en) 1999-09-10
IL137653A0 (en) 2001-10-31
BG104740A (en) 2001-02-28
AU3294799A (en) 1999-09-20
HUP0100865A2 (hu) 2001-08-28
AR018139A1 (es) 2001-10-31
HUP0100865A3 (en) 2001-11-28
JP2002505323A (ja) 2002-02-19
KR20010041584A (ko) 2001-05-25
AP1244A (en) 2004-02-04
CN1214011C (zh) 2005-08-10
HRP20000574A2 (en) 2001-08-31
PL342726A1 (en) 2001-07-02
CN1291978A (zh) 2001-04-18
NO20004316D0 (no) 2000-08-30
OA11530A (en) 2004-05-17
ID25591A (id) 2000-10-19
TR200002542T2 (tr) 2001-05-21
EP1060164A1 (en) 2000-12-20
SK13002000A3 (sk) 2001-07-10
NO315703B1 (no) 2003-10-13
GEP20033118B (en) 2003-11-25
EA200000804A1 (ru) 2001-04-23
AP2000001893A0 (en) 2000-09-30
NZ506598A (en) 2003-07-25
UA71906C2 (en) 2005-01-17
AU753230B2 (en) 2002-10-10

Similar Documents

Publication Publication Date Title
ZA994406B (en) Meta-azacyclic amino benzoic acid and derivatives thereof.
GB9806815D0 (en) Amino acid derivatives
EP1024130A4 (en) BIPHENYL-5-ALKANIC ACID DERIVATIVES AND THEIR USE
GB9623908D0 (en) Amino acid derivatives
PL334997A1 (en) Derivatives or arylosulphonyl-hydroxamic acid
IL139470A0 (en) Oxyiminoalkanoic acid derivatives
EP1111048A4 (en) NEUTRAL AMINO ACID TRANSPORTER AND CORRESPONDING GENE
DK1089726T3 (da) Præparat omfattende beta-hydroxy-beta-methylsmørsyre og mindst en aminosyre
ZA987126B (en) Aryloxyarylsulfonylamino hydroxamic acid derivatives.
HU9801044D0 (en) Sulfonyl-amino-carboxylic acid derivatives
PL348349A1 (en) Antrhranilic acid amides and the use thereof as medicaments
HUP0003881A3 (en) Amidocarboxylic acid derivatives
HK1035525A1 (en) Aminomethylcarboxylic acid derivatives
ZA974542B (en) New amino acid derivatives and their use as thrombin inhibitors.
IL143095A0 (en) 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
HK1034969A1 (en) Dihydroxyhexanoic acid derivatives.
HUP0100597A3 (en) Hydroxamic and carboxylic acid derivatives
ZA9811655B (en) Phenylaminoalkylcarboxylic acid derivatives and pharmaceutical compositions comprising the same
AU6120298A (en) 2-peperazinone-1-acetic acid derivatives and their use
EP1171151A4 (en) THROMBOSPONDIN-2 AND ITS USES
GB9910935D0 (en) Amino acid sequence
HK1039609A1 (zh) 甲氧基亞氨基苯基乙酰胺
ZA985940B (en) Amino acid derivatives
GB9930708D0 (en) MUS101 and homologues thereof
ZA99979B (en) Hydroxamic and carboxylic acid derivatives.